Cingulate Inc.CINGNASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank50
3Y CAGR-20.6%
Studio
Year-over-Year Change

Year-over-year research & development expense growth

3Y CAGR
-20.6%/yr
Annual compound
Percentile
P50
Within normal range
vs 3Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
20253.48%
2024-39.04%
202372.24%
20226.95%
202165.13%
2020-44.00%
20190.00%